Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 10, 2006 - Issue 2
Submit an article Journal homepage
32
Views
2
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease

ITO K, ITO M, ELLIOTT WM et al.: Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. (2005) 352(19):1967-1976 Citation

Sabina A Antoniu Clinic of Pulmonary Disease, 30 Dr I Cihac Str, 700115 Iasi, Romania. [email protected]
Pages 329-332 | Published online: 21 Mar 2006

Bibliography

  • ITO K, ITO M, ELLIOTT WM et al.: Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. (2005) 352(19):1967-1976.
  • CELLI BR, MACNEE W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. (2004) 23(6):932-946.
  • DI STEFANO A, CAPELLI A, DONNER CF: Role of interleukin-8 in the pathogenesis and treatment of COPD. Chest (2004) 126(3):676-678.
  • YAGI O, AOSHIBA K, NAGAI A: Activation of nuclear factor-kappaB in airway epithelial cells in patients with chronic obstructive pulmonary disease. Respiration (2005) Epub ahead of print.
  • BARNES PJ, ADCOCK IM, ITO K: Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. (2005) 25(3):552-563.
  • MARKS PA, DOKMANOVIC M: Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin. Investig. Drugs (2005) 14(12):1497-1511.
  • COSIO BG, MANN B, ITO K et al.: Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am. J. Respir. Crit. Care Med. (2004) 170(2):141-147.
  • ITO K, CARAMORI G, LIM S et al.: Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. (2002) 166(3):392-396.
  • ITO K, LIM S, CARAMORI G et al.: Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB. J. (2001) 15(6):1110-1112.
  • MARWICK JA, KIRKHAM PA, STEVENSON CS et al.: Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am. J. Respir. Cell. Mol. Biol. (2004) 31(6):633-642.
  • BARNES PJ, ITO K, ADCOCK IM: Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet (2004) 363(9410):731-733.
  • BARNES PJ: Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment. Expert Opin. Ther. Targets (2005) 9(6):1111-1121.
  • CHEN L, FISCHLE W, VERDIN E, GREENE WC: Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science (2001) 293(5535):1653-1657.
  • ITO K, BARNES PJ, ADCOCK IM: Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. (2000) 20(18):6891-6903.
  • KEATINGS VM, JATAKANON A, WORSDELL YM, BARNES PJ: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. (1997) 155(2):542-548.
  • SPENCER S, CALVERLEY PM, BURGE PS, JONES PW: Impact of preventing exacerbations on deterioration of health status in COPD. Eur. Respir. J. (2004) 23(5):698-702.
  • BARNES PJ: Corticosteroid resistance in airway disease. Proc. Am. Thorac. Soc. (2004) 1(3):264-268.
  • BARNES PJ: Theophylline in chronic obstructive pulmonary disease: new horizons. Proc. Am. Thorac. Soc. (2005) 2(4):334-339; discussion 340-331.
  • KOBAYASHI M, NASUHARA Y, BETSUYAKU T et al.: Effect of low-dose theophylline on airway inflammation in COPD. Respirology (2004) 9(2):249-254.

Website

  • www.goldcopd.com The GOLD Workshop Report (Updated 2005). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.